What risk level is Nortriptyline for workers compensation claims?

Nortriptyline is classified as Low risk (2 risk points) by AllMeds. Tricyclic antidepressant with anticholinergic effects and potential for cardiac arrhythmias.

Can you work or drive while taking Nortriptyline?

Nortriptyline is a CNS depressant that may cause sedation, drowsiness, and impaired coordination. It can affect driving ability and work capacity, particularly in safety-sensitive roles. Work capacity should be assessed on a case-by-case basis.

What should a case manager know about Nortriptyline?

Case managers should note that Nortriptyline is Low risk. It is a CNS depressant that may affect work capacity. Recommended maximum duration is 180 days. Always check for drug interactions with other medications on the claim.

Antidepressant_tca | Low Risk

Nortriptyline (Allegron)

Q: What schedule is Nortriptyline in Australia?

Nortriptyline is classified as S4 under the Therapeutic Goods Administration (TGA) in Australia.

What to know about Nortriptyline — also sold as Allegron: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.

Nortriptyline (brand names: Allegron) is classified as Low risk (2 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. Tricyclic antidepressant with anticholinergic effects and potential for cardiac arrhythmias.

Key Takeaways

TGA Schedule: S4 in Australia
Risk level: Low (2 points)
CNS depressant: May cause sedation, impair driving, and affect work capacity
Serotonergic: Risk of serotonin syndrome when combined with other serotonergic drugs
Recommended maximum duration: 180 days
PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme

Scheduling and Classification

Jurisdiction	Classification	Status
Australia (TGA)	S4	PBS listed

Risk Profile

Risk Level Low

Risk Points 2

CNS Depressant Yes

Respiratory Risk No

Max Duration 180 days

Tricyclic antidepressant with anticholinergic effects and potential for cardiac arrhythmias.

How Nortriptyline is regulated

Nortriptyline is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.

Work capacity impact: As a CNS depressant, Nortriptyline may impair driving, operating machinery, and cognitive function. Work capacity certificates should reflect any medication-related restrictions.

Australia TGA / PBS / State Schemes

Classified as S4 under the Therapeutic Goods Administration (TGA).

Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.

United Kingdom NICE / MHRA / FPM

NICE guidelines recommend certain antidepressants (amitriptyline, duloxetine) for chronic pain management. For personal injury claims, antidepressant prescribing should be assessed for injury relatedness.

UK drug driving laws (Section 5A Road Traffic Act 2006) set specific limits for prescription drugs that cause impairment. Employers and occupational health advisors should assess fitness to work.

Check this medication against your full medication list

Run a full risk assessment including Nortriptyline interactions and compliance checks.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Try it free → Talk to Sales →

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.